Fattiviracin A1, a novel antiviral agent produced by Streptomyces microflavas strain no. 2445: II. Biological properties

Journal of Antibiotics

Volumn 51, Issue 11, 1998, Pages 1035-1039

  Yokomizo, Kazumi ^a   Miyamoto, Yoshiaki ^a   Nagao, Kazuhiko ^a   Kumagae, Etsuko ^a   Habib, El Sayed E ^a   Suzuki, Keitarou ^a   Harada, Shinji ^a   Uyeda, Masaru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FATTIVIRACIN A1; NEW DRUG; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; HERPES SIMPLEX VIRUS 1; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; STREPTOMYCES; VARICELLA ZOSTER VIRUS; VERO CELL; VIRUS INFECTIVITY; VIRUS INHIBITION;

STREPTOMYCES MICROFLAVAS;

EID: 0031730578     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.51.1035     Document Type: Article

References (12)

1. UYEDA, M.; K. YOKOMIZO, Y. MIYAMOTO & E. HABIB: Fattiviracin A1, a novel antiherpetic agent produced by Streptomyces microflavus strain No. 2445. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation. J. Antibiotics 51: 823-828, 1998
2. SCHINAZI, R. F.; J. PETERS, C. C. WILLIAMS, D. CHANCE & A. J. NAHMIAS: Effect of combinations of acyclovir with vidarabine or its 5′-monophosphate on herpes simplex viruses in cell culture and in mice. Antimicrob. Agents Chemother. 22: 499-507, 1982
3. HARADA, S.; Y. KOYANAGI & N. YAMAMOTO: Infection of HTLV-III/LAV in HTLV-1-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566, 1985
4. WAKSMAN, S. A. & H. C. REILLY: Agar-streak method for assaying antibiotic substance. Ind. Eng. Chem., Anal. Ed. 17: 556-557, 1945
5. ELION, G. B.; P. A. FURMAN, J. A. FYFE, P. DE MIRANDA, L. BEUCHAMP & H. J. SCHAEFFER: Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl. Acad. Sci. USA 54: 5716-5720, 1977
6. 2. I. Production, isolation, physico-chemical properties and biological activity. J. Antibiotics 45: 1467-1471, 1992
7. 2. II. Structure determination. J. Antibiotics 45: 1472-1480, 1992
8. SNIPES, W.; S. PERSON, G. KELLER, W. TAYLOR & A. KEITH: Inactivation of lipid-containing viruses by long-chain alcohols. Antimicrob. Agents Chemother. 11: 98-104, 1977
9. SANDS, J.; D. AUPERIN & W. SNIPES: Extreme sensitivity of enveloped viruses, including herpes simplex, to long-chain unsaturated monoglycerides and alcohols. Antimicrob. Agents Chemother. 15: 67-73, 1979
10. KATZ, D. H.; J. F. MARCELLETTI, M. H. KHALIL, L. E. POPE & L. R. KATZ: Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex. Proc. Natl. Acad. Sci. USA 88: 10825-10829, 1991
11. THORMAR, H.; C. E. ISAACS, K. S. KIM & H. R. BROWN: Inactivation of visna virus and other enveloped viruses by free fatty acids and monoglycerides. Ann. NY. Acad. Sci. 724: 465-471, 1994
12. THORMAR, H.; C. E. ISAACS, H. R. BROWN, M. R. BARSHATZKY & T. PESSOLANO: Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob. Agents Chemother. 31: 27-31, 1987